看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。0 P7 ?* H0 W$ o8 B S
/ l$ q( m& k! k# l
! t) I/ X* K GCurrently available feasibility data for possible combination strategies.
- }" W, n" s: l; d4 l8 S2 e————————————————————————————————+ v6 l/ s' b$ C4 W# q1 j9 Z
Combination Feasibility according to preliminary data
& y; }6 O |/ O9 `7 ]8 z——————————————————————————————————
! D6 i+ ]' U) Q0 x- u2 p( aBevacizumab + sorafenib Yes, reduced dose
" J/ d& `7 P. f1 ZBevacizumab + sunitinib† No - y+ m( W4 l1 g' s8 D' k# z
Bevacizumab + temsirolimus Yes
! Z; P7 P% J" x+ R: A9 mBevacizumab + everolimus Yes
) M- c- f9 P9 ~, K; ]Sorafenib + sunitinib ? % U1 h: s9 q; b& ?
Sorafenib + temsirolimus Yes, reduced dose
}0 U: b! L' o0 ?6 @3 }( SSorafenib + everolimus Yes, reduced dose
: o- z. u1 N2 t. A+ ?3 ~. \6 }Sunitinib + temsirolimus† No
7 H/ \7 X% T, @Sunitinib + everolimus ? $ ]6 e2 a4 n: b
Temsirolimus + everolimus ?
, b( ]8 Q+ Z; n" M. \7 s1 i2 l————————————————————
. [( F z- n; D/ F7 A9 T†Led to US FDA warning.- |$ [" \' T0 c! U
?: As yet unattempted combination.- ]/ B; V+ s$ a7 y1 @& b9 t5 q8 a
|